Despite this new evidence, the challenges for future studies remain: (i) to explain why NLGase loss of function with concomitant increase of GCase could result in GlcCer accumulation and (ii) which are the molecular mechanisms linking the NLGase-dependent GlcCer accumulation with the onset of spastic ataxia. The gene discussed is GBA2; the disease is spastic ataxia.